Nisha Nanda
8Patents
3h-index
6Co-inventors
39Inventor score
Filing activity: Oct 26, 2016 → Jan 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10045991B2 | Methods of treating pediatric cancers | Human Necessities | 9 | Active |
| US10655186B2 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Physics | 3 | Active |
| US10724102B2 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Physics | 3 | Active |
| US10378068B2 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Physics | 3 | Active |
| US10370727B2 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Physics | 3 | Active |
| US10907215B2 | Point mutations in TRK inhibitor-resistant cancer and methods relating to the same | Physics | 3 | Active |
| US10588908B2 | Methods of treating pediatric cancers | Human Necessities | 2 | Active |
| US11191766B2 | Methods of treating pediatric cancers | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.